logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

GOSS
Gossamer Bio, Inc.
0.17
4 x 0.16
2 x 0.16
bid
ask
+
0.00
1.88%
3 @ 06:32 AM
0.17 +0.01 (4.00%)
Ytd-94.59%
1y-86.58%
0.16
day range
0.17
0.14
52 week range
3.87
Open0.17Prev Close0.16Low0.16High0.17Mkt Cap81.98M
Vol11.30MAvg Vol11.93MEPS-0.79P/EN/AForward P/E-1.24
Beta1.96Short Ratio6.29Inst. Own77.48%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg0.25200-d Avg1.661yr Est7.61

GOSS News

Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants
businesswire.com
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured F

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a bioph

benzinga.com
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $2

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a B

benzinga.com
Gossamer Bio Completes Debt Exchange, Converting $181M Of 2027 Notes Into New Secured Notes And Equi

Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company" or "Gossamer"), a biopharmaceutical